South San Francisco biotech files for what could be first Bay Area IPO of 2019
December 28, 2018 at 09:41 AM EST
Harpoon Therapeutics is developing proteins to direct infection-fighting T cells to better identify and attack tumor cells.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|